AzTrials
AzTrials

DepressionCANDONCT04388800

Online Cognitive Behavioral Intervention Program for Hong Kong People With Depression

A study testing Confront and Navigate Depression Online (CANDO) in people with Depression, run by Hong Kong Baptist University at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to develop a culturally and linguistically appropriate online cognitive behavioral intervention program-- with therapist guidance -- for Hong Kong Chinese adults suffering from major depressive disorder with mild to moderate depressive symptoms, and examine the effectiveness of this… Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Depression
What is being tested?
Confront and Navigate Depression Online (CANDO)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
402 participants
Where
1 siteHong Kong
Study dates
1 Jan 2019to 30 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Hong Kong resident
  • Has mild to moderate depressive symptoms
  • No suicidal risk in the past 3 months
  • Receive no face-to-face counselling since program commencement
  • Has access to a computer/smartphone with internet access
  • Has a valid email address

Who cannot join

  • Has severe or no depressive symptoms
  • Has suicidal risk in the past 3 months
  • Currently receiving other psychological treatment
  • Suffer from severe psychiatric conditions, such as bipolar disorder or schizophrenia
  • Has no computer or smartphone with internet access
  • Has no valid email address

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • Jiayan Pan

    Hong Kong

Other trials in Hong Kong

About this study

Official title: Development of an Online Cognitive Behavioral Intervention Program to Reduce Depressive Symptoms for Hong Kong People With Depression

The purpose of this study is to develop a culturally and linguistically appropriate online cognitive behavioral intervention program-- with therapist guidance -- for Hong Kong Chinese adults suffering from major depressive disorder with mild to moderate depressive symptoms, and examine the effectiveness of this program in reducing their depressive symptoms and improving their mental health. The 3- and 6-month maintenance effect after 3 months and 6 months will also be tested.

Read the detailed description

Previous studies have demonstrated that online cognitive behavioral therapy can significantly reduce depressive symptoms and improve mental health for people with depression. This project will develop an online cognitive behavioral intervention program (including both an online platform and a smartphone application) for Hong Kong people with depression. Blended mode will be delivered service, which include 8-week online program, 2 face-to-face sessions and 2 telephone follow-ups by a clinical psychologist. The program will be evaluated in its effectiveness in reducing depressive and anxiety symptoms, psychological distress, negative thoughts and negative emotions and increasing positive thoughts and positive emotions.

Conditions
Depression
Being tested
Confront and Navigate Depression Online (CANDO)
Keywords
online cognitive behavioral intervention, Hong Kong Chinese, depression
Medical subject headings
Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Confront and Navigate Depression Online (CANDO)Other

    This study adopts a blended mode of service delivery, which included both online and offline intervention. The online intervention includes 8 weekly online model, animation briefing and debriefing, case demonstration video, exercise, forum, internal messaging, reminder, online assessment, session review and online booking system. The offline intervention includes two face-to-face sessions and two telephone follow-ups.

Study groups in NCT04388800
Study groupRoleWhat they receive
web-based cognitive behavioral interventionExperimentalThe web-based program is consisted of 8 online modules, forum, internal messaging, reminder, online assessment and online booking. Each online module contains mood check, animation briefing and debriefing, case demonstration videos, session review and exercise. Blended mode is adopted to deliver service, which includes the online program, two face-to-face session and 2 telephone follow-ups with a clinical psychologist.
Receives: Other: Confront and Navigate Depression Online (CANDO)
app-based cognitive behavioral interventionExperimentalApp-based cognitive behavioral intervention program The App-based program is consisted of 8 online modules, forum, internal messaging, reminder, online assessment and online booking. Each online module contains mood check, animation briefing and debriefing, case demonstration videos, session review and exercise. Blended mode is adopted to deliver service, which includes the online program, two face-to-face session and 2 telephone follow-ups with a clinical psychologist
Receives: Other: Confront and Navigate Depression Online (CANDO)
Wait-list control groupNo interventionNo intervention will be provided when the experimental group is receiving services, but the access to the app-based program will be delivered to the wait-list control group after the two experimental groups complete the service.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Beck Depression Inventory-II (BDI-II)

    21-item rating scale for depressive symptoms

    Measured: 6 months

  2. Patient Health Questionnaire-9 (PHQ-9)

    9-item rating scale for depressive symptoms.

    Measured: 6 months

Secondary outcomes (5)
  1. General Health Questionnaire-12 (GHQ-12)

    12 item rating scale for psychological distress.

    Measured: 6 months

  2. Beck Anxiety Inventory (BAI)

    21-item rating scale for symptoms of anxiety.

    Measured: 6 months

  3. Chinese Automatic Thoughts Questionnaire (CATQ)

    20-item rating scale for automatic thoughts.

    Measured: 6 months

  4. Chinese Affect Scale (CAS)

    20-item rating scale for positive and negative emotions of Chinese-speaking people.

    Measured: 6 months

  5. Negative effects Questionnaire (NEQ) (administered at post-test only)

    20-item rating scale for negative effects caused by psychological treatment

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 May 2020
  2. Study start1 Jan 2019
  3. Primary completion30 Jun 2022
  4. Study completion30 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
randomized controlled trial
Masking
None (open label)
Enrolment
402 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04388800
Sponsor's protocol ID
ITB/FBL/5002/18/P
Acronym
CANDO
Status last verified
Sep 2023
First submitted
12 May 2020
Last updated
22 Sep 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Pan JY, Rafi J. Culturally Adapted Guided Internet-Based Cognitive Behavioral Therapy for Hong Kong People With Depressive Symptoms: Randomized Controlled Trial. J Med Internet Res. 2025 Feb 25;27:e64303. doi: 10.2196/64303.

    PubMed 39998865

Questions about this trial

What is this clinical trial studying?

A study testing Confront and Navigate Depression Online (CANDO) in people with Depression, run by Hong Kong Baptist University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Beck Depression Inventory-II (BDI-II) (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04388800, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in